Long-term Review of a Cohort of Arthroscopic Bankart Interventions

NCT ID: NCT03654118

Last Updated: 2018-08-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

125 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-08-07

Study Completion Date

2017-11-09

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Recurrent instability is the most common chronic shoulder pathology of the young and athletic patient. It is a source of functional, sporting and professional disability, and a permanent apprehension to the use of the affected shoulder.

Surgical treatment has been proposed for a long time by the reintegration of the labrum (intervention of Bankart) then by the making of an osteo-muscular stop (intervention of Latarjet).

Like in many domains, surgical techniques have evaluated towards the search for endoscopic alternatives to open surgery, more deleterious.

Bankart's intervention has been performed arthroscopically since the 1980s and remains the majority intervention in the United States. However, its success rate never reached that of open techniques, Bankart and Latarjet. Surgeons therefore sought the predictors of these failures in order to define the limits of the indications for arthroscopic Bankart intervention.

The determination and use of the preoperative instability score (Instability Severity Index Score : ISIS) described by Balg and Boileau is one of the ways to clarify these indications.

The aim of this study is to prospectively establish the values of the ISIS score to obtain an acceptable recurrence rate of long-term instability

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Recurrent Anterior Shoulder Instability

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Arthroscopy Bankart Shoulder ISIS

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ISIS cohort

Patients operated between December 2007 and December 2008 for recurrent shoulder instability using the arthroscopic procedure (Arthroscopic Bankart) in the investigative centers and presenting at the time of indication for surgery an ISIS score ≤ 4 points

Phone follow-up

Phone follow-up

Intervention Type OTHER

Through a short phone interview :

* Determination of a complication (Infection, capsulitis, recurrence)
* Determination of the Rowe score
* Determination of the Walch-Duplay score

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Phone follow-up

Through a short phone interview :

* Determination of a complication (Infection, capsulitis, recurrence)
* Determination of the Rowe score
* Determination of the Walch-Duplay score

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Major patient
* Patient who already volunteered in a first ISIS study


* Patients operated between December 2007 and December 2008 for recurrent shoulder instability, according to the arthroscopic procedure (Arthroscopic Bankart) in the investigative centers and presenting at the time of the indication of operation an ISIS score of ≤ 4 points (regardless of the positive criteria) (see Annex 2- ISIS score)
* Age\> 16 years
* Supported by a joint arthroscopic technique completed.
* Patient not objecting to his participation in the study

Exclusion Criteria

* First dislocation or resumption of another technique at the time of indication for surgery
* Voluntary or multidirectional instability at the time of the indication of operation
* Painful shoulder without instability felt at the time of the operative indication
* Lesion of the cap (perioperative report)
* Humeral lesions Avulsion Gleno-humeral Ligament (per-operative finding)
* Unsuccessful technique
* Major benefiting from a legal protection measure (safeguard of justice, trusteeship, guardianship)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Rennes University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hervé THOMAZEAU, MD, PhD

Role: STUDY_DIRECTOR

Rennes University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clinique parc Rambot Provençale

Aix-en-Provence, , France

Site Status

Clinique Générale d'Annecy

Annecy, , France

Site Status

Hôpital Ambroise Paré

Boulogne-Billancourt, , France

Site Status

Clinique du Cambresis

Cambrai, , France

Site Status

Clinique des Cèdres

Échirolles, , France

Site Status

Clinique François 1er

Le Havre, , France

Site Status

Clinique du Sport de Bordeaux-Mérignac

Mérignac, , France

Site Status

Hôpital Archet II

Nice, , France

Site Status

Hôpital Saint-Antoine / APHP

Paris, , France

Site Status

Clinique Turin

Paris, , France

Site Status

Centre Hospitalier Universitaire de RENNES

Rennes, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2017-A01665-48

Identifier Type: OTHER

Identifier Source: secondary_id

35RC17_3025

Identifier Type: -

Identifier Source: org_study_id